Cyted Health Expands US Presence with First Patients Enrolled in DETECT-ME Clinical Validation Study
WILMINGTON, Del. and CAMBRIDGE, England, March 25, 2025 /PRNewswire/ — Cyted Health, a leading gastrointestinal molecular diagnostics company, today announces the enrollment of the first patient in the DETECT-ME clinical validation study (NCT06803927). The study evaluates Cyted Health’s advanced molecular assays using esophageal cells... Read More →
Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom
For Investigational Purposes, Nanowear’s app, platform, and server will transmit Dexcom G7 CGM data, offering first-in-the-world, home-based, self-administered, continuous cardiometabolic assessments NEW YORK–(BUSINESS WIRE)–Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software... Read More →
Fujifilm strikes partnership with Us2.ai for AI echocardiography analysis
Us2.ai’s AI-based software is being integrated into Fujifilm’s LISENDO ultrasound systems to expedite cardiology image analysis. Fujifilm is collaborating with Singapore-based company Us2.ai to integrate the company’s AI-based image analysis software into the clinical workflows of the LISENDO 880 and... Read More →
Diagnosing diseases and saving lives with AI featuring IMVARIA
Dr. Joshua Reicher, co-founder and CEO of IMVARIA, initially missed the opportunity to develop a company similar to DraftKings and instead decided to focus on saving lives. As a serial entrepreneur, he has been committed to using artificial intelligence to... Read More →
AtaCor Medical Enrolls First Patients in its ASCEND EV Clinical Study
SAN CLEMENTE, Calif., March 24, 2025 /PRNewswire/ — AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today that it has initiated its ASCEND EV study. The prospective, non-randomized international study aims to evaluate... Read More →
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience EXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) — Lungpacer Medical today announced the appointment of Kevin Kearney as Chief Commercial Officer (CCO). Kearney brings over 20 years... Read More →
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
HAYWARD, Calif., March 21, 2025 /PRNewswire/ — Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn’s Chief Transformation Officer, will transition... Read More →
Sibel Health Announces Close of New Series C Financing and New FDA 510(k) Clearance
CHICAGO, March 20, 2025 /PRNewswire/ — Sibel Health, an award-winning medical technology company, is pleased to announce the closing of $30 million in new equity financing and its 7th FDA 510(k) clearance. The equity financing was led by Sibel’s existing... Read More →
Stanford Medicine and LEADOPTIK Announce Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
SAN JOSE, Calif., March 19, 2025 /PRNewswire/ — LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has entered into a research collaboration with Stanford Medicine to explore the use of AI-enhanced real-time optical imaging in lung... Read More →
Moon Surgical gets FDA nod for AI-enhancement for surgical robot
Moon Surgical announced today that it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot. The Paris-based company also announced further integrations with Nvidia technologies, including the Isaac for Healthcare platform. Read More